Gilead Sciences Inc buy BMO Capital Markets
Start price
16.05.23
/
50%
€73.00
Target price
16.05.24
€91.88
Performance (%)
-14.51%
End price
17.05.24
€62.41
Summary
This prediction ended on 17.05.24 with a price of €62.41. The prediction for Gilead Sciences Inc disappointed with a performance of -14.51%. Dividends of €2.79 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Gilead Sciences Inc | 4.595% | 4.595% | 0.987% |
iShares Core DAX® | 0.039% | 0.567% | 12.281% |
iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten